Description
Learning Outcomes and Lectures
After completing this course, the learner should be able to:
Explain the impact of PET imaging on the diagnosis and understanding of dementia.
Discuss the benefits of novel imaging agents for oncology.
Describe the landscape of therapeutic radiopharmaceuticals.
Describe the role of nuclear medicine in theranostics.
Speakers and Lectures
Breakthroughs in PET for Neurodegenerative Diseases—P. Kuo
Breakthroughs in PET for Oncologic Imaging—K. Zukotynski
Breakthroughs in Radiotherapeutics and Theranostics—D. Yoo